Status:
COMPLETED
Effect of Hydroxyethylstarch 6% 130/0.4 Administration on Renal Function After Cardiac Surgery
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Kidney Function Tests
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Recent studies have shown an increased incidence of renal replacement therapy after the use of Hydroxyethylstarchs (HES) in patients admitted in the intensive care unit. However, studies showing detri...
Eligibility Criteria
Inclusion
- All patients undergoing cardiac surgery
Exclusion
- Heart transplantation
- Ventricular assist devices
- Patients requiring extracorporeal life support before or after cardiac surgery
- Patients revised for bleeding and/or tamponnade presenting with hemodynamic instability
- Patients in whom the administered volume therapy was not completely available
- Subjects who required renal replacement therapy before surgery
- Trauma patients who were put on cardiopulmonary bypass
- Patients who died intra-operatively or soon after arrival in the intensive care unit in whom no postoperative creatinine measurements were available
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
1564 Patients enrolled
Trial Details
Trial ID
NCT02306213
Start Date
January 1 2011
End Date
April 1 2013
Last Update
December 3 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.